- Home
- GRND vs PRGO Comparison
GRND vs PRGO Comparison
Compare GRND & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRND
- PRGO
- Stock Information
- Founded
- GRND 2009
- PRGO 1887
- Country
- GRND United States
- PRGO Ireland
- Employees
- GRND N/A
- PRGO N/A
- Industry
- GRND Computer Software: Prepackaged Software
- PRGO Biotechnology: Pharmaceutical Preparations
- Sector
- GRND Technology
- PRGO Health Care
- Exchange
- GRND Nasdaq
- PRGO Nasdaq
- Market Cap
- GRND 3.1B
- PRGO 3.3B
- IPO Year
- GRND N/A
- PRGO 1991
- Fundamental
- Price
- GRND $17.32
- PRGO $24.26
- Analyst Decision
- GRND Strong Buy
- PRGO Buy
- Analyst Count
- GRND 5
- PRGO 4
- Target Price
- GRND $18.80
- PRGO $35.00
- AVG Volume (30 Days)
- GRND 869.2K
- PRGO 1.4M
- Earning Date
- GRND 03-06-2025
- PRGO 02-25-2025
- Dividend Yield
- GRND N/A
- PRGO 4.46%
- EPS Growth
- GRND N/A
- PRGO N/A
- EPS
- GRND N/A
- PRGO N/A
- Revenue
- GRND $319,101,000.00
- PRGO $4,392,000,000.00
- Revenue This Year
- GRND $32.46
- PRGO N/A
- Revenue Next Year
- GRND $23.09
- PRGO $4.56
- P/E Ratio
- GRND N/A
- PRGO N/A
- Revenue Growth
- GRND 31.79
- PRGO N/A
- 52 Week Low
- GRND $7.93
- PRGO $23.14
- 52 Week High
- GRND $18.43
- PRGO $33.96
- Technical
- Relative Strength Index (RSI)
- GRND 58.38
- PRGO 37.77
- Support Level
- GRND $15.85
- PRGO $23.19
- Resistance Level
- GRND $17.34
- PRGO $24.83
- Average True Range (ATR)
- GRND 0.53
- PRGO 0.76
- MACD
- GRND -0.12
- PRGO -0.04
- Stochastic Oscillator
- GRND 59.19
- PRGO 31.19
About GRND Grindr Inc.
Grindr Inc is a social networking app for gay, bi, trans, and queer people. It is a social network that brings together gay and bisexual men who want to meet other men close to them in a completely discreet and anonymous way, without having to give any personal information or having to fill out a profile with confidential information in order to register.
About PRGO Perrigo Company plc
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.